Skip to main content

About Experimental Biology and Medicine

Scope

The Translational Research category is interested in research that connects or moves the study in one discipline to another. Particularly for biomedicine, translational research is the research that relates basic and clinical research to medical or industrial application. As such, it includes a wide range of biological, medical, chemical, pharmacological, engineering, and computational studies that aim at elucidating the mechanism of a biological or disease related pathological function/process, or applying such mechanistic understanding to the generation of new knowledge/strategies with clinical or industrial implication. We are interested in publishing original and high-quality research that meets the goal and definition of translational research as described above. This may include (not limited to) studies in the following example areas: (1) identification or characterization of a biological target or signaling pathway involved in a disease pathology or therapeutic invention; (2) discovery and development of novel therapeutic or diagnostic methods or agents with implications for clinical or industrial application; (3) study of the mechanism of action of currently used drugs or new experimental agents at the molecular, cellular or systems level; (4) clinical research for novel experimental therapeutics or new applications of existing drugs or that reveals mechanistic insight into a disease process or new targets or approaches for clinical intervention or prevention; (5) development of new tools or methods by chemical, engineering, nanotechnology or computational techniques that can be applied to study biology or human diseases; and (6) genetic, proteomic or systems biological study to reveal new markers, pathways or targets for clinical application. Reports of pure clinical methods, tools, procedures, or observations without molecular, cellular or systems investigation of mechanism or insight into new mechanism or target for clinical treatment or detection are not acceptable. Studies of alternative medicine without mechanistic investigations as described above are also not accepted. For chemical, computational or engineering studies of molecular systems, some biological or clinical results must be presented, or in the absence of such data, such molecular systems should have clear potential for biological or medical application.

Associate Editor

Chia-Ching (Josh) Wu, National Cheng Kung University, Taiwan

Review Editors

Jing An, MD, PhD, University of California San Diego, USA

Pan Pan Chong, PhD, University of Malaya, Malaysia

Hyacinth I. Hyacinth, MD, PhD, MPH, University of Cincinnati, USA

Monica Jablonski, University of Tennessee Health Science Center, Hamilton Eye Institute, USA

Chulso Moon, MD, PhD, HJM Research Foundation, USA

Esther A. Obeng, MD, PhD, St. Jude Children’s Research Hospital, USA

Athena Starland-Davenport, University of Tennessee Health Science Center, USA

Advisory board and editorial team

SEBM’s Publications Committee and EBM’s Editorial Board provides strategic and professional advice to the Editor-in-Chief. The journal recognizes the following Editorial Board members for their continuous guidance and support of the journal: 

Editor-in-Chief

Nicola Conran, University of Campinas, Brazil

Deputy Editor

Sulev Koks, Murdoch University, Perth, Australia

Assistant to the Editor-in-Chief

Benjamin Zimmer, Society for Experimental Biology and Medicine, Washington D.C., USA

Africa Editor

Gordon Awandare, PhD, University of Ghana, Africa

Asia Editor

Shaw-Jeng Tsai, PhD, National Cheng-Kung University Medical College, Taiwan

Americas Editor

Nicola Conran, PhD, University of Campinas, Brazil

Europe Editor

Farzin Farzaneh, PhD, King's College London, UK

Australia/Oceana Editor

Sulev Koks, Murdoch University, Perth, Australia



Call for new associate editors

Experimental Biology and Medicine is looking for new Associate Editors. In particular we welcome applications from researchers with a good track record of publications in the following areas:

  • Clinical trials

  • RNA Biology

  • Synthetic biology

  • Systems biology

At the Society for Experimental Biology and Medicine, we value the benefits that diversity brings. If you are interested in joining the Editorial Board, please complete this form.

Selection criteria

  • An active researcher with a PhD and preferably a tenured academic position

  • Evidence of an active and relevant publication record for current career stage

  • Expertise in relevant subject areas within the scope of the journal

  • Experience of reviewing (essential)

Key responsibilities

  • Acting as handling editor for manuscripts submitted to the journal

  • Helping develop the journal including:

    • Suggesting Special Issues for the journal

    • Acting as a Guest Editor on Special Issues

  • Assisting editorial team to identify papers for further promotion

  • Acting as an ambassador for the journal at conferences and engaging with the journal through social media, as appropriate

  • The journal is supported by professional editorial office staff which works to support all Editorial Board members in these activities.

Application assessment

The deadline for applications is March 31st, 2025.

Journal information

  • Short name

    Exp. Biol. Med.

  • Abbreviation

    EBM

  • Electronic ISSN

    1535-3699

  • Impact

    2.8 Impact Factor

    6 CiteScore

  • Indexed in

    AGRICOLA, ProQuest Algology, Mycology and Protozoology Abstracts (Microbiology C), ProQuest Bacteriology Abstracts (Microbiology B), ProQuest Biological Science Database, CAB Abstracts, Chemical Abstracts Service (CAS), BIOSIS Previews, Biological Abstracts, Web of Science Science Citation Index Expanded (SCIE), Embase, Abstracts in Anthropology Online , AgBiotechNet, Gale, ProQuest Industrial and Applied Microbiology Abstracts (Microbiology A), MEDLINE, WorldCat Discovery Service (OCLC), ProQuest Nucleic Acids Abstracts, PubMed, Scopus, Agroforestry Abstracts, Animal Breeding Abstracts, Animal Science Database, ArticleFirst, Biochemistry & Biophysics Citation Index, Botanical Pesticides Abstracts, CABI: Abstracts on Hygiene and Communicable Diseases, CABI: Agricultural Economics Database, CABI: Dairy Science Abstracts, CABI: Environmental Impact, CABI: Forest Products Abstracts, CABI: Forest Science Database, CABI: Forestry Abstracts, CABI: Global Health, CABI: Nutrition and Food Sciences Database, CABI: Tropical Diseases Bulletin, CABI: Veterinary Science Database, Chemical Abstracts Student Edition, Chemoreception Abstracts (Online), Selective, Crop Physiology Abstracts, Current Contents, Directory of Open Access Journals (DOAJ), EBSCOhost: Biological Abstracts (Online), Elsevier BV: BIOBASE, Environmental Sciences and Pollution Management, Priority, Helminthological Abstracts, Horticultural Science Database, IBZ - Internationale Bibliographie der Geistes- und Sozialwissenschaftlichen Zeitschriftenliteratur, Internationale Bibliographie der Rezensionen Geistes- und Sozialwissenschaftlicher Literatur, Maize Abstracts, Nematological Abstracts, Nutrition Abstracts and Reviews Series B, Parasitology Database, Personal Alert (E-mail), Pharmacoeconomics and Outcomes News, Plant Breeding Abstracts, Plant Genetic Resources Abstracts, Plant Genetics and Breeding Database, Plant Growth Regulator Abstracts, Postharvest Abstracts, Potato Abstracts, Poultry Abstracts, ProQuest, ProQuest: CSA Neurosciences Abstracts, ProQuest: Calcium and Calcified Tissue Abstracts, Protozoological Abstracts, Reactions Weekly, Review of Medical and Veterinary Entomology, Review of Plant Pathology, Rice Abstracts, Small Animals, Soybean Abstracts, Sugar Industry Abstracts, TropAg & Rural, Virology and AIDS Abstracts, Web of Science, Weed Abstracts, Wildlife Review Abstracts, World Agricultural Economics and Rural Sociology Abstracts

Impact Metrics 

The 2023 2-year Impact Factor is 2.8. This places the journal in the 2nd quartile of the ‘Medicine, Research and Experimental’ category.

The 2023 5-year Impact Factor is 3.5

The 2023 CiteScore is 6.0. This places the journal in the 73rd percentile of the ‘Biochemistry, Genetics and Molecular Biology’ category.

Journal categories

Open access statement

Open access logo

EBM provides online free gold open access to the journal and all of its research publications.

Open Access funder and institutional mandates: EBM is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution license  (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in EBM. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.

Quality

Each EBM article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers. EBM encourages authors to consult the instructions for authors guidelines prior to submission.

Contact

Frontiers Editorial Office

Avenue du Tribunal Fédéral 34

CH – 1005 Lausanne

Switzerland

For queries regarding thematic issues, fee support, and any other questions, please contact development@ebm-journal.org

For all queries regarding manuscripts in review or potential conflicts of interest, please contact ebm@ebm-journal.org

EBM Editorial Offices

For any additional questions or queries, please contact bzimmer@sebm.org

IT HelpDesk

For technical issues, please visit our HelpDesk, or contact our IT HelpDesk team at support@ebm-journal.org